Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.

Prasher, P; Sharma, M; Mehta, M; Paudel, KR; Satija, S; Chellappan, DK; Dureja, H; Gupta, G; Tambuwala, MM; Negi, P; Wich, PR; Hansbro, NG; Hansbro, PM; Dua, K

Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.

Prasher, P Sharma, M Mehta, M Paudel, KR Satija, S

Chellappan, DK Dureja, H Gupta, G Tambuwala, MM Negi, P Wich, PR Hansbro, NG Hansbro, PM Dua, K

Permalink

Publisher:: Elsevier BV
Publication Type:: Journal Article
Citation:: Chemico-biological interactions, 2020, 325, pp. 109125
Issue Date:: 2020-05-04

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

The embargo period expires on 31 Jul 2022

Adobe PDF

Download Accepted Manuscript VersionAdobe PDF (1.79 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Prasher, P
dc.contributor.author	Sharma, M
dc.contributor.author	Mehta, M
dc.contributor.author	Paudel, KR
dc.contributor.author	Satija, S https://orcid.org/0000-0003-4702-6534
dc.contributor.author	Chellappan, DK
dc.contributor.author	Dureja, H
dc.contributor.author	Gupta, G
dc.contributor.author	Tambuwala, MM
dc.contributor.author	Negi, P
dc.contributor.author	Wich, PR
dc.contributor.author	Hansbro, NG
dc.contributor.author	Hansbro, PM
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2020-05-29T07:56:23Z
dc.date.available	2020-04-29
dc.date.available	2020-05-29T07:56:23Z
dc.date.issued	2020-05-04
dc.identifier.citation	Chemico-biological interactions, 2020, 325, pp. 109125
dc.identifier.issn	0009-2797
dc.identifier.issn	1872-7786
dc.identifier.uri	http://hdl.handle.net/10453/140993
dc.description.abstract	The apparent predicament of the representative chemotherapy for managing respiratory distress calls for an obligatory deliberation for identifying the pharmaceuticals that effectively counter the contemporary intricacies associated with target disease. Multiple, complex regulatory pathways manifest chronic pulmonary disorders, which require chemotherapeutics that produce composite inhibitory effect. The cost effective natural product based molecules hold a high fervor to meet the prospects posed by current respiratory-distress therapy by sparing the tedious drug design and development archetypes, present a robust standing for the possible replacement of the fading practice of poly-pharmacology, and ensure the subversion of a potential disease relapse. This study summarizes the experimental evidences on natural products moieties and their components that illustrates therapeutic efficacy on respiratory disorders.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier BV
dc.relation	http://purl.org/au-research/grants/nhmrc/GNT1079187
dc.relation.ispartof	Chemico-biological interactions
dc.relation.isbasedon	10.1016/j.cbi.2020.109125
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.subject	0601 Biochemistry and Cell Biology
dc.subject.classification	Toxicology
dc.title	Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.
dc.type	Journal Article
utslib.citation.volume	325
utslib.location.activity	Ireland
utslib.for	0601 Biochemistry and Cell Biology
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	open_access	*
utslib.copyright.embargo	2022-07-31T00:00:00+1000Z
dc.date.updated	2020-05-29T07:56:21Z
pubs.publication-status	Published
pubs.volume	325
utslib.start-page	109125

Abstract:

The apparent predicament of the representative chemotherapy for managing respiratory distress calls for an obligatory deliberation for identifying the pharmaceuticals that effectively counter the contemporary intricacies associated with target disease. Multiple, complex regulatory pathways manifest chronic pulmonary disorders, which require chemotherapeutics that produce composite inhibitory effect. The cost effective natural product based molecules hold a high fervor to meet the prospects posed by current respiratory-distress therapy by sparing the tedious drug design and development archetypes, present a robust standing for the possible replacement of the fading practice of poly-pharmacology, and ensure the subversion of a potential disease relapse. This study summarizes the experimental evidences on natural products moieties and their components that illustrates therapeutic efficacy on respiratory disorders.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/140993